Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China
· Delayed Price · Currency is CNY 22.56
-0.01 (-0.04%)
Apr 29, 2026, 3:00 PM CST
SHA:600285 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 12,711 | 11,663 | 12,480 | 9,649 | 7,358 | 8,920 | Upgrade
|
| Market Cap Growth | 7.07% | -6.54% | 29.34% | 31.14% | -17.51% | 85.47% | Upgrade
|
| Enterprise Value | 12,284 | 10,864 | 11,552 | 8,482 | 6,324 | 8,108 | Upgrade
|
| Last Close Price | 22.57 | 20.71 | 21.32 | 15.93 | 11.70 | 13.62 | Upgrade
|
| PE Ratio | 16.24 | 15.36 | 17.27 | 16.98 | 15.81 | 24.67 | Upgrade
|
| Forward PE | 14.67 | 13.59 | 16.50 | 16.45 | 15.43 | 15.43 | Upgrade
|
| PS Ratio | 3.21 | 3.03 | 3.57 | 2.91 | 2.45 | 3.31 | Upgrade
|
| PB Ratio | 3.45 | 3.39 | 4.05 | 3.45 | 2.88 | 3.90 | Upgrade
|
| P/TBV Ratio | 4.47 | 4.51 | 4.35 | 3.73 | 3.14 | 4.37 | Upgrade
|
| P/FCF Ratio | 19.66 | 23.47 | 16.40 | 12.18 | 9.11 | 11.60 | Upgrade
|
| P/OCF Ratio | 18.04 | 21.06 | 14.25 | 11.86 | 8.81 | 10.55 | Upgrade
|
| EV/Sales Ratio | 3.10 | 2.82 | 3.30 | 2.56 | 2.11 | 3.01 | Upgrade
|
| EV/EBITDA Ratio | 12.56 | 11.64 | 14.52 | 12.76 | 13.65 | 18.11 | Upgrade
|
| EV/EBIT Ratio | 14.09 | 12.96 | 15.96 | 14.40 | 16.25 | 21.54 | Upgrade
|
| EV/FCF Ratio | 19.00 | 21.86 | 15.19 | 10.71 | 7.83 | 10.55 | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.12 | 0.03 | 0.07 | 0.06 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 0.29 | 0.42 | 0.12 | 0.31 | 0.34 | 0.63 | Upgrade
|
| Debt / FCF Ratio | 0.44 | 0.80 | 0.13 | 0.26 | 0.20 | 0.37 | Upgrade
|
| Net Debt / Equity Ratio | -0.13 | -0.04 | -0.46 | -0.49 | -0.51 | -0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.48 | -0.15 | -1.78 | -2.09 | -2.80 | -2.10 | Upgrade
|
| Net Debt / FCF Ratio | -0.72 | -0.29 | -1.86 | -1.75 | -1.60 | -1.22 | Upgrade
|
| Asset Turnover | 0.70 | 0.72 | 0.72 | 0.73 | 0.74 | 0.74 | Upgrade
|
| Inventory Turnover | 2.00 | 1.77 | 1.88 | 1.86 | 1.83 | 1.86 | Upgrade
|
| Quick Ratio | 0.76 | 0.60 | 1.07 | 1.11 | 1.16 | 1.16 | Upgrade
|
| Current Ratio | 1.17 | 1.08 | 1.31 | 1.37 | 1.47 | 1.48 | Upgrade
|
| Return on Equity (ROE) | 22.57% | 23.40% | 24.58% | 21.21% | 19.21% | 15.73% | Upgrade
|
| Return on Assets (ROA) | 9.58% | 9.84% | 9.24% | 8.08% | 5.98% | 6.49% | Upgrade
|
| Return on Invested Capital (ROIC) | 23.30% | 29.32% | 41.04% | 38.32% | 26.85% | 21.97% | Upgrade
|
| Return on Capital Employed (ROCE) | 23.10% | 23.80% | 23.00% | 20.50% | 14.80% | 16.00% | Upgrade
|
| Earnings Yield | 6.21% | 6.51% | 5.79% | 5.89% | 6.32% | 4.05% | Upgrade
|
| FCF Yield | 5.09% | 4.26% | 6.10% | 8.21% | 10.98% | 8.62% | Upgrade
|
| Dividend Yield | 3.99% | - | 4.22% | 5.02% | 5.13% | 3.67% | Upgrade
|
| Payout Ratio | 64.75% | 67.32% | 62.47% | 60.60% | 62.08% | 61.91% | Upgrade
|
| Buyback Yield / Dilution | -0.59% | -0.64% | 0.42% | 0.30% | -0.26% | 0.24% | Upgrade
|
| Total Shareholder Return | 3.60% | -0.64% | 4.64% | 5.33% | 4.87% | 3.91% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.